Investigator
Laura Michelle Heath
SAGE BIONETWORKS · funded by NIA
- Companies
- 3
- Grants
- 3
- Non-dilutive funding
- $4.3M
- First award
- Sep 30, 2018
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Sep 1, 2025.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- SAGE BIONETWORKSMomentum in another area
NeuroPhase II
- SAGE BIONETWORKSMomentum in another area
NeuroGrant-only
- SAGE BIONETWORKSMomentum in another area
NeuroGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- U24
Advancing cross-disease comparisons through FAIR data practices to uncover shared molecular mechanisms between Alzheimer's disease and autoimmune disorders
$437kSep 1, 2025NIASAGE BIONETWORKSNIH RePORTER · 11362998 (opens the source filing in a new tab)
- U24
Tox-AD: a new multi-institute tri-consortium data resource in the AD Knowledge Portal
$436kSep 1, 2025NIASAGE BIONETWORKSNIH RePORTER · 11362994 (opens the source filing in a new tab)
- U24
The AD Knowledge Portal Data Coordination Center
$3.4MSep 30, 2018NIASAGE BIONETWORKSNIH RePORTER · 11166349 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources